先天性黑素细胞痣核心结局指标集(OCOMEN项目)第二部分:临床实践与研究中的领域与结局
最终纳入9个临床实践核心结局和10个研究核心结局,为未来标准化报告及下一步选择测量工具奠定基础。
要点
- CMN核心结局集共纳入9个临床实践结局和10个研究结局。
- 该结局集旨在标准化CMN照护与研究的结局报告。
核心结论
- 先天性黑素细胞痣(CMN)的临床实践与研究分别纳入9个和10个核心结局,将支持未来标准化报告。
研究设计与样本
- OCOMEN研究团队先经在线问卷由利益相关者审阅暂定结局列表并完善定义,必要时电话或邮件讨论。
- 随后召开在线共识会议讨论结局纳入,会后由参与者进行两轮投票。
主要发现
- 最终纳入9个核心结局用于临床实践,10个核心结局用于研究。
临床怎么用
- 临床实践与研究可采用该核心结局集进行标准化报告,便于比较结局并支持管理决策。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Congenital melanocytic naevi (CMN) can have a great impact on patients' lives owing to perceived stigmatization, and the risk of melanoma development and neurological complications. Development of a core outcome set (COS) for care and research in CMN will allow standard reporting of outcomes. This will enable comparison of outcomes, allowing professionals to offer advice about the best management options. In previous research, stakeholders (patients, parents and professionals) reached consensus on the core domains of the COS. To select the appropriate measurement instruments, the domains should be specified by outcomes. OBJECTIVES: To reach consensus on the specific core outcomes describing the core domains pertaining to clinical care and research in CMN. METHODS: A list of provisional outcomes (obtained earlier) was critically reviewed by the Outcomes for COngenital MElanocytic Naevi (OCOMEN) research team and by relevant stakeholders through an online questionnaire, to refine this list and provide clear definitions for every outcome. When needed, discussion with individual participants was undertaken over the telephone or by email. During an online consensus meeting, stakeholders discussed the inclusion of potential outcomes. After the meeting, participants voted in two rounds for the inclusion of outcomes. RESULTS: Forty-four stakeholders from 19 countries participated. Nine core outcomes were included in the COS relative to clinical care and 10 core outcomes for research. CONCLUSIONS: These core outcomes will enable standard reporting in future care and research of CMN. This study facilitates the next step of COS development: selecting the appropriate measurement instruments for every outcome.
引用
- Fledderus AC, Pasmans SGMA, Wolkerstorfer A, et al. Domains and outcomes of the core outcome set of congenital melanocytic naevi for clinical practice and research (the OCOMEN project): part 2. Br J Dermatol. 2021. PMID: 33959942. doi:10.1111/bjd.20437
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。